Abstract
Riboswitches are RNA elements that control gene expression through metabolite binding. The preQ1 riboswitch exhibits the smallest known ligand-binding domain and is of interest for its economical organization and high affinity interactions with guanine-derived metabolites required to confer tRNA wobbling. Here we present the crystal structure of a preQ1 aptamer domain in complex with its precursor metabolite preQ0. The structure is highly compact with a core that features a stem capped by a well organized decaloop. The metabolite is recognized within a deep pocket via Watson-Crick pairing with C15. Additional hydrogen bonds are made to invariant bases U6 and A29. The ligand-bound state confers continuous helical stacking throughout the core fold, thus providing a platform to promote Watson-Crick base pairing between C9 of the decaloop and the first base of the ribosome-binding site, G33. The structure offers insight into the mode of ribosome-binding site sequestration by a minimal RNA fold stabilized by metabolite binding and has implications for understanding the molecular basis by which bacterial genes are regulated.
Riboswitches are naturally occurring, structured motifs in the 5′-untranslated regions of a handful of mRNAs. It has been estimated that these elements regulate the expression of 3–4% of bacterial genes (1). Their mechanism of action entails “sensing” a cellular metabolite via a high affinity aptamer domain, which alters the accessibility of flanking mRNA sequences necessary for control of transcription or translation (2, 3). Respective riboswitches have been discovered that sense more than a dozen distinct small molecules (reviewed in Ref. 4), and these RNA-regulatory elements have been identified in the genomes of several human pathogens (5–7). As such, elucidating the principles by which riboswitches bind their cognate ligands is critical for the identification and validation of new antibiotic targets (8, 9).
Queuosine (Q)5 is a hypermodified variant of guanosine necessary for wobbling of certain tRNAs (10). This modification improves translational accuracy (11–13) and pervades both prokaryotic and eukaryotic phyla. De novo Q synthesis occurs only in bacteria, requiring that humans acquire it from gut flora or dietary sources (14). Production of Q begins with GTP and proceeds via formation of the metabolic intermediate preQ0 (see Fig. 1A, inset), the antecedent to preQ1 (15). Breaker and co-workers (16) discovered recently that some genes encoding proteins whose function is preQ1 uptake or biosynthesis are regulated by riboswitches responsive to this metabolite and its analogs. Equilibrium dialysis revealed that a representative riboswitch aptamer favors preQ1 binding over preQ0 by only 5-fold, with preQ0 displaying a Kd of ∼100 nm (16). Phylogenetic comparisons suggested a stem-loop secondary structure (see Fig. 1A) that could be divided further into two aptamer “types” based on sequence differences in the L1 region.
FIGURE 1.
Secondary structure of the preQ1 type I aptamer domain, preQ metabolites, and electron density maps. A, diagram of the predicted RNA secondary structure; the sequence is derived from T. tengcongensis (locus 1564) (16). The conservation key is: boxed residues >95% and shaded >80%. Black residues represent the bacterial sequence with red denoting purine and blue signifying pyrimidine preferences. Inset, chemical drawings of preQ0 and preQ1. QueF is the nitrile reductase gene product in this pathway. B, representative MAD, solvent-flattened electron density at 1.5 σ (teal) and 5.0 σ (yellow) at 3.1 Å resolution with the final refined model (sticks). Residues from the A-rich segment in A (orange, left) begin at A24 (lower) and proceed to A28 (upper). Regions from the Watson-Crick stem (right, red) begin at G20 (lower) and proceed to C16 (upper). C, σA-weighted 2Fo – Fc electron density at 2.75 Å resolution using αcalc from the final refined coordinates. Contour levels were set to match B.
In contrast to other riboswitches, the preQ1 aptamer is unusually small (∼34 nucleotides), which is ∼2.5-fold shorter than functionally similar purine riboswitches (17). To elucidate the molecular basis by which this minimal riboswitch binds its cognate ligand to modulate gene expression, we determined the structure of a type I, preQ1 riboswitch at 2.75 Å resolution. The results reveal the mode of ligand binding and support a mechanism of translational regulation that features metabolite-induced RNA folding to sequester the RBS. This work represents an important step in elucidating a mode of gene regulation that controls cellular levels of a metabolite unique to bacteria.
EXPERIMENTAL PROCEDURES
Choice of Aptamer Construct and RNA-Ligand Preparation—The preQ1 aptamer domain (see Fig. 1A) was derived from sequence and biochemical analyses that described its minimal architecture (16). Conserved elements include the P1 stem and L1 loop, as well as a downstream A-rich sequence. These regions were protected in the presence of metabolite under “in-line” cleavage conditions (16). Although several aptamer sequences were prepared and subjected to crystallization, including that from the well studied Bacillus subtilis, a 33-mer from Thermoanaerobacter tengcongensis (see Fig. 1A) was favored due to its small size and hot spring origins (18), which has precedents for RNA crystallization (19). All RNA sequences were synthesized by Dharmacon Inc. (Fayette, CO) followed by in-house deprotection, high pressure liquid chromatography purification, and desalting (20).
Pure preQ0 was produced enzymatically (21). Approximately 2 mg of material was added to 25 ml of “Q0 buffer” comprising 10 mm sodium cacodylate, pH 7.0, 10 mm MgCl2, and 5% (v/v) 1,3-propanediol. This solution was heated to 85 °C for 1 h and then centrifuged at 10,000 × g. PreQ0 was soluble to ∼0.5 mm as assessed by absorbance at 275 nm using an extinction coefficient of 12.9 mm–1 cm–1. A 5-ml volume of Q0 buffer was then heated to 65 °C.
Lyophilized aptamer RNA was suspended in 0.01 m sodium cacodylate buffer, pH 7.0, to a concentration of 0.7 mm. A total of 50 μl was mixed slowly with the 65 °C Q0 buffer. Once the entire 5-ml volume was added, the solution was incubated at 65 °C for 3 min and then moved to a 0.5-liter water bath at 65 °C. The bath was allowed to slow-cool to 28 °C over 2 h. Meanwhile, a Vivaspin 2 centrifugal filter with a 3-kDa molecular mass cut-off (GE Healthcare) was pre-equilibrated with 1 ml of Q0 buffer using a FIBERLite F21 rotor (FIBERLite, Santa Clara, CA) and a force of 4500 × g. The dilute aptamer solution was applied to the filter and centrifuged for 30-min intervals at 22 °C. Progress was monitored by UV absorption at 260 nm. To correct for the absorbance of preQ0 in the flow-through, a blank was prepared from water plus a volume of Q0 buffer equal to the volume of the measured sample. The sample solution remained clear throughout the concentrating process. The final concentration of the aptamer-preQ0 complex was ∼0.55 mm.
Crystallization, Cryoprotection, and Heavy Atom Derivatization—Crystals of the aptamer-ligand complex were screened by hanging drop vapor diffusion experiments against a sparse matrix designed for RNA (20). Multiple crystal habits were observed from precipitating agents such as 2-methyl-2,4-pentanediol, poly(ethylene) glycol, and high salt. Superior crystals were obtained at 20 °C from 2-μl:2-μl mixtures of RNA-ligand complex with precipitant comprising: 1.8 m Li2SO4, 0.10 m sodium cacodylate, pH 6.0, 0.01 m MgSO4, 5% (v/v) 1,3-propanediol, and 2 mm spermine. Crystals grew as hexagonal rods to dimensions of 0.2 × 0.2 × 0.4 mm in 3–4 weeks and were harvested into a “stabilizing” mother liquor of 2.0 m Li2SO4, 0.10 m sodium cacodylate, pH 6.0, 0.02 m MgSO4, 5% (v/v) 1,3-propanediol, 2 mm spermine, and saturating amounts of preQ0. Native crystals were cryoprotected by passage through a fresh, 1:1 mixture of silicon and paratone-N oils (Hampton Research). The aqueous hydration layer around the crystal was removed by repeated grazing of the surface with a 20-μm nylon loop (Hampton Research). After ∼5 min under oil, the crystal was captured in a nylon loop and flash-cooled by plunging into N2(l).
A heavy atom derivative was prepared by soaking crystals in solutions of pentaammine-(trifluoro-methane-sulfonato) Os(III) triflate (Sigma-Aldrich). Due to the limited solubility and reactivity of heavy atom compounds in the Li2SO4 mother liquor, crystals were adapted from the stabilization solution into a final derivative solution of 4.0 m LiC2H3O2, 20 mm Mg(C2H3O2)2, 0.10 m sodium cacodylate, pH 6.5, 5% (v/v) 1,3-propanediol, 2 mm spermine, saturating preQ0, and 0.10 m Os(NH3)5-triflate. Gradual removal of SO2–4 and maintenance of ionic strength entailed 1:3, 1:1, and 3:1 combinations of the stabilizing mother liquor with the derivative mother liquor. Each transfer lasted 15 min. Crystals were allowed to react with osmium for 4 h and showed no signs of osmotic shock or hysteresis. Previously, we reported that high acetate levels serve as a vitrification agent for RNA crystals (20). As such, crystals were flash-cooled by direct plunging into N2(l). Loop-mounted crystals were loaded into a 96-position cassette (Crystal Positioning Systems) at N2(l) temperature and shipped to the Stanford Synchrotron Radiation Laboratory (SSRL, Menlo Park, CA) for x-ray data collection.
X-ray Structure Determination and Refinement—X-ray diffraction data were collected remotely at beamline 7-1 of SSRL using the Blu-Ice and Web-Ice interfaces (22). Respective native and preliminary derivative data sets were recorded at a crystal-to-detector distance of 32.5 cm as 320 × 0.5° oscillations using a Quantum 315 CCD detector (ADSC); exposure times were 20 s per degree. Native crystals diffracted anistropically between 2.75 and 2.55 Å resolution. Intensity data were reduced using the HKL2000 suite (23) with intensity statistics provided in supplemental Table S1. Space group P6322 was assigned based on the Laue symmetry of 6/mmm and the observation of l = 2n + 1 systematic absences for the 00l class of reflections.
Derivatization by Os(NH3)5-triflate was identified by local scaling of derivative and native data sets, which produced a 19% isomorphous difference. A fluorescence scan of a fresh Os(NH3)5-triflate crystal produced f′ and f″ values of: –15.6 e, 13.8 e (peak); –7.2 e, 10.8 e (remote); and –20.4 e, 8.9 (inflection) as determined by CHOOCH (24). A multiwavelength anomalous diffraction (MAD) experiment was conducted using dose mode with inverse beam geometry collected in 30° wedges to match Friedel pairs. Reflections were reduced as described for native, but keeping Ihkl and Ih–k–l– separate. Intensity statistics for the MAD data sets are provided in supplemental Table S1.
Two osmium sites were located and refined using SOLVE (25). A useful MAD signal was observed to 3.5 Å resolution. The application of density modification and phase extension to 3.1 Å resolution in RESOLVE (26) revealed clear RNA structure (see Fig. 1B) corresponding to one molecule per asymmetric unit. The resulting experimental, density-modified phases were subjected to PHENIX (27) for phase combination using the “build_rna” option. Although the resulting electron density maps were greatly improved by placement of the RNA polymer, PHENIX did not produce a reasonable aptamer model and could not fit the input sequence. Manual building was conducted using experimental and phase-combined maps in the graphics program O (28). The resulting model was subjected to positional and individual B-factor refinement against the native data set in CNS (29). The strong anisotropic component of the intensity data is reflected in the B-factor correction applied to Fobs (B11 = –21, B22 = –21, B33 = 42). Target geometry for preQ0 refinement was prepared using XPLO2D (30) from a small molecule crystal structure BOVYEQ retrieved from the Cambridge Structural Database (31). Two sulfate ions were observed and modeled with partial occupancy, which lowered Rfree. All structure-derived graphics were produced in PyMOL (32). Coordinates and structure factor amplitudes are available from the Protein Data Bank (PDB) as entry 3gca.
RESULTS AND DISCUSSION
Structure Determination and Quality Indicators of the PreQ1 Aptamer Domain—To discover how a type I, preQ1 riboswitch employs a highly economical fold to recognize its cognate metabolite, we solved the structure of the T. tengcongensis aptamer domain in complex with preQ0 by MAD phasing. The quality of the experimental phases is indicated by the excellent agreement of initial electron density maps with the final refined coordinates (Fig. 1B). The presence of the A-rich backbone segment (orange) running parallel to the minor grove of the P1 stem (red) is distinctive at 3.1 Å resolution. Electron density was visible for several bases in this region as well, although the L1 region was less clear due to its irregular structural features. Electron density for the refined structure (Fig. 1C) is provided for comparison with the MAD maps. The refined structure exhibits strong, continuous electron density for all backbone atoms. All bases are ordered except U12 (Fig. 2), which is unstacked and protrudes into solvent. The average B-factor for all RNA atoms is 76 Å2 (on scale of 400 Å2). The final model produced an Rwork of 24.5% with Rfree = 27.2%, suggesting that the model was not over fit (33). The root mean square deviations from ideal bonds and angles were 0.008 Å and 1.5°, respectively, which is comparable with other RNA structures of this size and resolution (34, 35). Refinement statistics are summarized in supplemental Table S1.
FIGURE 2.
Schematic diagrams of the preQ1 aptamer-domain fold. A, secondary structure and nucleotide-interaction diagram adapted from RNAVIEW (42). The color code is: red, Watson-Crick pairs (triple or double solid lines); orange, A-rich segment; purple, non-canonical base interactions with preQ0; slate letters and circles, decaloop and A-rich segment bases engaged in base triples (above the preQ0 ring); blue letters and circles, bases involved in the ribose zipper; and teal, phosphate backbone connectivity or unstacked bases. Interactions are: W, Watson-Crick face; S, sugar edge; and H, Hoogsteen edge. B, schematic representation of the preQ1 aptamer domain. The phosphate backbone is indicated by a teal ribbon. PreQ0 is indicated by a ball-and-stick model.
Global Fold of the PreQ1 Riboswitch—When one considers that an RNA duplex is 20 Å, the triple-stranded preQ1 aptamer domain appears relatively compact with dimensions of 48 × 28 Å × 15 Å (Fig. 2A); indeed, more than half of all bases engage in triplet pairs (Fig. 2A). As one proceeds from the 5′- to 3′-end, nearly one-third of all bases comprise stem P1 (Fig. 2, A and B). The flanking L1 decaloop is the site of metabolite binding and reveals numerous non-canonical nucleotide interactions. A sharp bend in this loop occurs at residue A10. Here a Watson-Crick pair forms between C9 and G33, the 3′-most base of the aptamer construct, that facilitates the sharp change in direction. The nearby base G11 resides in the heart of the L1 loop and forms a Watson-Crick pair with C30 of the A-rich segment; G11 stacks directly upon preQ0 (discussed below). Thus, when the metabolite is bound, an uninterrupted base stack forms throughout the aptamer beginning with G33, passing through G11 and preQ0, and culminating with G20 at the 3′-end of the P1 stem.
A ribose zipper (supplemental Fig. S1A) involving bases U2, A19, and A23 facilitates another sharp bend that joins the 3′-P1 stem to the A-rich segment (Fig. 2). A comparable interaction exists in the 23 S rRNA (36) between C1476, C1477, and A2681 (supplemental Fig. S1B). Due to the intrastrand nature of these respective interactions, as well as the absence of a second canonical 2′-OH-to-minor-groove interaction, this motif has been classified as a “pseudo cis” ribose zipper (37). Nonetheless, the presence of this structural feature in two highly divergent RNA sequences is illustrative of the point that RNA adopts recognizable tertiary contacts that are readily classified and potentially predictable.
The ribose zipper represents a transition point for base stacking of residues in the A-rich segment. Beginning at A24 and proceeding through C30, a nearly continuous base stack forms (Fig. 2B). Remarkably, each base of the phylogenetically conserved A-rich segment (Fig. 1A) utilizes either its Watson-Crick or its Hoogsteen face to interact with the sugar edge of the P1 stem (Fig. 2). This trend continues beyond the stem and culminates with the A28-to-U6 Hoogsteen-to-Watson-Crick pairing. Importantly, this architecture primes the structure for formation of the metabolite-binding pocket in which the Watson-Crick face of A29 is poised to interact with ligand (Fig. 2B). The conserved C30 base is the last residue of the A-rich segment to stack upon the preceding 5′-bases and culminates with a canonical pairing to G11 located in the core of the L1 decaloop (Fig. 2).
The Metabolite-binding Pocket—To discover the mode of ligand binding, we co-crystallized the aptamer in the presence of preQ0. A simulated annealing-omit electron density map (Fig. 3A) indicates the quality of the ligand model. The average B-factor for preQ0 was 58 Å2, which is among the lowest in the structure but comparable with the surrounding core RNA atoms. PreQ0 itself is sequestered in a deep pocket within the L1 loop of the aptamer. The walls of the pocket comprise three strands contributed by the decaloop and the A-rich segment (Fig. 3, A and B).
FIGURE 3.
Schematic interactions with the preQ0 metabolite. A, stereo view of a σA-weighted Fo – Fc simulated-annealing omit electron density map for C15 and preQ0 (ball-and-stick model) at 3σ. Broken lines indicate putative hydrogen bonds. The flanking underlying the G5:C16 base pair from stem P1 is depicted as a semitransparent red surface. The orientation is similar to Fig. 2B (lower right). B, a base quartet stacked above the preQ0 plane. The color scheme is derived from Fig. 2.
Specific structural interactions to the ligand were predicted by phylogenetic and biochemical analyses (16). The structure supports the observation that the conserved base C15 engages in a Watson-Crick pair with the ligand (Fig. 3A), which accounts for the dramatic loss of metabolite affinity when C15 is mutated or the ligand is substituted with adenine (16). Such direct Watson-Crick readout of purine metabolites was observed for the guanine and adenine riboswitch aptamers (17, 38). However, this shared mode of ligand recognition is simply an instance of convergent evolution. This is because the spatial organization of the preQ1 aptamer observed here, as well as its diminutive size, refutes the possibility that it originated from an ∼80-nucleotide purine-binding ancestor, which appears to be the case for the adenine and guanine riboswitches (17). Additional hydrogen bond contacts to preQ0 include invariant bases U6 and A29. These interactions can be considered the walls of the binding pocket. Although the O4 keto group of U6 receives a hydrogen bond from the N-9 imino of preQ0, A29 utilizes its Watson-Crick face to recognize the N2 amino group of the ligand. These observations, as well as the aforementioned Watson-Crick pairing to C15, account for why hypoxanthine, which lacks an exocyclic amine at N2, loses ∼103-fold in binding affinity relative to guanine. Finally, an additional hydrogen bond interaction is observed between the O6 keto moiety of preQ0 and the 2′-hydroxyl of G11. This position is not highly conserved, which fits structural observations with regard to ligand binding.
In addition to hydrogen bonding, the preQ0 ligand engages in several base-stacking interactions that promote core packing of the decaloop and A-rich tail elements. From the P1 stem, the G5:C16 pair forms a “floor” within the ligand-binding pocket (Fig. 3A). Conversely, a ceiling is formed by a base quartet featuring C7, G11, A14, and C30 (Fig. 3B). This arrangement effectively buries 300 of 338 Å2 of preQ0 surface area with nitrogen of the nitrile moiety being most solvent-exposed (Fig. 3, A and B). An additional base triple stacks over the ligand ceiling (supplemental Fig. S2), forming a broad “roof” upon which to assemble the final tertiary interaction that unites C9 of the decaloop with G33 at the 3′-terminus.
Implications for PreQ1 Binding and Translational Control—PreQ0 and preQ1 differ by a single amino group attached to atom C-7 of the nitrile moiety (Fig. 1A). This difference accounted for a 5-fold reduction in relative affinity for preQ0 (16). From an energetic standpoint, the N-7 amine of preQ1 contributes ∼1 kcal mole–1 to the stability of the RNA-ligand complex or two hydrogen bonds (39). Thus, although all the interactions described here are expected to dictate both preQ0 as well as preQ1 specificity and affinity, the mode of N-7 recognition for the latter is unknown at present. However, because the sp3 C-NH2 hybridization of preQ1 at the methyl-amine moiety allows it to freely rotate, it is plausible that preQ1 interacts with the neighboring O-6 of G5, an invariant residue. In contrast, the sp-hybridized nitrile group of preQ0 cannot donate a hydrogen bond and must remain linear. Another possibility is that nearby U12, which is unstacked from the core fold (Fig. 2B), changes conformation upon preQ1 binding to effectively close the “lid” on the metabolite-binding pocket. A pyrimidine is favored at this position, which would support base unstacking and the need for flexibility. Ultimately, elucidation of the final specificity determinant for preQ1 must await additional analyses.
The riboswitch of this investigation was derived from the 5′-untranslated region of a gene encoding a putative preQ1 permease from T. tengcongensis (16). Import of preQ1 or its analogs would therefore promote riboswitch aptamer folding as described here. As such, the means by which permease translation is diminished in a preQ1-rich environment could be through the sequestration of the RBS sequence GGGAG, in which the underlined position is G33 of the aptamer domain. Furthermore, the ability of the metabolite to mediate core folding through RNA base stacking, as well as directed interactions to the A-rich segment at A29, suggests that the aptamer-ligand complex functions as an integrated unit to sequester the RBS and 5′-regions, thus blocking translation. Such a mechanism has been cited for other riboswitches (40). This mode of gene regulation is distinct from “kinetic” mechanisms that produce competing terminator versus anti-terminator structures (2, 41).
The riboswitch presented here is one of the smallest known aptamer motifs and provides a plausible mechanism for metabolite recognition and translational arrest. Efforts to grow crystals in the absence of metabolites have not been fruitful, making it unclear to what extent the aptamer domain folds prior to ligand binding. Another open question is whether divergent bacterial species use the same principles of ligand recognition as the T. tengcongensis aptamer domain presented here. A phylogenetic comparison suggests that many organisms preserve the C9:G33 Watson-Crick pair, but this mode of binding to the RBS is not universal. As such, additional investigations will be required to develop an understanding of preQ1 aptamer recognition by a diverse number of organisms. This effort is likely to reveal subgroups within the type I and II domains. Such work will be essential to advance biomedical efforts aimed at targeting riboswitches that control production of bacterial-specific metabolites.
Supplementary Material
Acknowledgments
We thank Prof. Clara L. Kielkopf for helpful suggestions and insights. We are grateful to Drs. Clyde Smith and Ana González for assistance with experimental design and apparatus at SSRL. SSRL is operated by Stanford on behalf of the U.S. Department of Energy. The SSRL Structural Molecular Biology Program is supported by the DOE and by National Institutes of Health/National Center for Research Resources and NIGMS.
This work was supported, in whole or in part, by National Institutes of Health Grant GM63162 (to J. E. W.).
The on-line version of this article (available at http://www.jbc.org) contains two supplemental figures and a supplemental table.
This article was selected as a Paper of the Week.
The atomic coordinates and structure factors (code 3gca) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
Footnotes
The abbreviations used are: Q, queuosine; preQ0, 7-cyano-7-deazaguanine; preQ1, 7-aminomethyl-7-deazaguanine; RBS, ribosome-binding site; MAD, multiwavelength anomalous diffraction.
References
- 1.Nudler, E. (2006) Cell 126, 19–22 [DOI] [PubMed] [Google Scholar]
- 2.Tucker, B. J., and Breaker, R. R. (2005) Curr. Opin. Struct. Biol. 15, 342–348 [DOI] [PubMed] [Google Scholar]
- 3.Wakeman, C. A., Winkler, W. C., and Dann, C. E., III (2007) Trends Biochem. Sci. 32, 415–424 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Cochrane, J. C., and Strobel, S. A. (2008) RNA (Cold Spring Harb.) 14, 993–1002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Barrick, J. E., Corbino, K. A., Winkler, W. C., Nahvi, A., Mandal, M., Collins, J., Lee, M., Roth, A., Sudarsan, N., Jona, I., Wickiser, J. K., and Breaker, R. R. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 6421–6426 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mandal, M., Boese, B., Barrick, J. E., Winkler, W. C., and Breaker, R. R. (2003) Cell 113, 577–586 [DOI] [PubMed] [Google Scholar]
- 7.Winkler, W. C., and Breaker, R. R. (2005) Annu. Rev. Microbiol. 59, 487–517 [DOI] [PubMed] [Google Scholar]
- 8.Lea, C. R., and Piccirilli, J. A. (2007) Nat. Chem. Biol. 3, 16–17 [DOI] [PubMed] [Google Scholar]
- 9.Blount, K. F., and Breaker, R. R. (2006) Nat. Biotechnol. 24, 1558–1564 [DOI] [PubMed] [Google Scholar]
- 10.Kasai, H., Oashi, Z., Harada, F., Nishimura, S., Oppenheimer, N. J., Crain, P. F., Liehr, J. G., von Minden, D. L., and McCloskey, J. A. (1975) Biochemistry 14, 4198–4208 [DOI] [PubMed] [Google Scholar]
- 11.Bienz, M., and Kubli, E. (1981) Nature 294, 188–190 [DOI] [PubMed] [Google Scholar]
- 12.Meier, F., Suter, B., Grosjean, H., Keith, G., and Kubli, E. (1985) EMBO J. 4, 823–827 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Urbonavicius, J., Qian, Q., Durand, J. M., Hagervall, T. G., and Bjork, G. R. (2001) EMBO J. 20, 4863–4873 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Iwata-Reuyl, D. (2003) Bioorg. Chem. 31, 24–43 [DOI] [PubMed] [Google Scholar]
- 15.Van Lanen, S. G., Reader, J. S., Swairjo, M. A., de Crecy-Lagard, V., Lee, B., and Iwata-Reuyl, D. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 4264–4269 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Roth, A., Winkler, W. C., Regulski, E. E., Lee, B. W., Lim, J., Jona, I., Barrick, J. E., Ritwik, A., Kim, J. N., Welz, R., Iwata-Reuyl, D., and Breaker, R. R. (2007) Nat. Struct. Mol. Biol. 14, 308–317 [DOI] [PubMed] [Google Scholar]
- 17.Serganov, A., Yuan, Y. R., Pikovskaya, O., Polonskaia, A., Malinina, L., Phan, A. T., Hobartner, C., Micura, R., Breaker, R. R., and Patel, D. J. (2004) Chem. Biol. 11, 1729–1741 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Xue, Y., Xu, Y., Liu, Y., Ma, Y., and Zhou, P. (2001) Int. J. Syst. Evol. Microbiol. 51, 1335–1341 [DOI] [PubMed] [Google Scholar]
- 19.Klein, D. J., and Ferre-D'Amare, A. R. (2006) Science 313, 1752–1756 [DOI] [PubMed] [Google Scholar]
- 20.Wedekind, J. E., and McKay, D. B. (2000) Methods Enzymol. 317, 149–168 [DOI] [PubMed] [Google Scholar]
- 21.Quaranta, D., McCarty, R., Bandarian, V., and Rensing, C. (2007) J. Bacteriol. 189, 5361–5371 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Soltis, S. M., Cohen, A. E., Deacon, A., Eriksson, T., Gonzalez, A., McPhillips, S., Chui, H., Dunten, P., Hollenbeck, M., Mathews, I., Miller, M., Moorhead, P., Phizackerley, R. P., Smith, C., Song, J., van dem Bedem, H., Ellis, P., Kuhn, P., McPhillips, T., Sauter, N., Sharp, K., Tsyba, I., and Wolf, G. (2008) Acta Crystallogr. Sect. D Biol. Crystallogr. 64, 1210–1221 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307–326 [DOI] [PubMed] [Google Scholar]
- 24.Evans, G., and Pettifer, R. F. (2001) J. Appl. Crystallogr. 34, 82–86 [Google Scholar]
- 25.Terwilliger, T. C. (1997) Methods Enzymol. 276, 530–537 [PubMed] [Google Scholar]
- 26.Terwilliger, T. C. (2000) Acta Crystallogr. Sect. D Biol. Crystallogr. 56, 965–972 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Adams, P. D., Gopal, K., Grosse-Kunstleve, R. W., Hung, L. W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Pai, R. K., Read, R. J., Romo, T. D., Sacchettin, J. C., Sauter, N. K., Storoni, L. C., and Terwilliger, T. C. (2004) J. Synchrotron. Rad. 11, 53–55 [DOI] [PubMed] [Google Scholar]
- 28.Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. Sect. A 47, 110–119 [DOI] [PubMed] [Google Scholar]
- 29.Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 905–921 [DOI] [PubMed] [Google Scholar]
- 30.Kleywegt, G. J., Henrick, K., Dodson, E. J., and van Aalten, D. M. (2003) Structure (Camb.) 11, 1051–1059 [DOI] [PubMed] [Google Scholar]
- 31.Allen, F. H. (2002) Acta Crystallogr. Sect. B Struct. Crystallogr. 58, 380–388 [DOI] [PubMed] [Google Scholar]
- 32.DeLano, W. L. (2002) The PyMOL Molecular Graphics System. DeLano Scientific, Palo Alto, CA
- 33.Adams, P. D., Pannu, N. S., Read, R. J., and Brunger, A. T. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 5018–5023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wedekind, J. E., and McKay, D. B. (1999) Nat. Struct. Biol. 6, 261–268 [DOI] [PubMed] [Google Scholar]
- 35.Alam, S., Grum-Tokars, V., Krucinska, J., Kundracik, M. L., and Wedekind, J. E. (2005) Biochemistry 44, 14396–14408 [DOI] [PubMed] [Google Scholar]
- 36.Harms, J., Schluenzen, F., Zarivach, R., Bashan, A., Gat, S., Agmon, I., Bartels, H., Franceschi, F., and Yonath, A. (2001) Cell 107, 679–688 [DOI] [PubMed] [Google Scholar]
- 37.Klosterman, P. S., Tamura, M., Holbrook, S. R., and Brenner, S. E. (2002) Nucleic Acids Res. 30, 392–394 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Batey, R. T., Gilbert, S. D., and Montange, R. K. (2004) Nature 432, 411–415 [DOI] [PubMed] [Google Scholar]
- 39.Klostermeier, D., and Millar, D. P. (2002) Biochemistry 41, 14095–14102 [DOI] [PubMed] [Google Scholar]
- 40.Winkler, W., Nahvi, A., and Breaker, R. R. (2002) Nature 419, 952–956 [DOI] [PubMed] [Google Scholar]
- 41.Winkler, W. C., and Breaker, R. R. (2003) ChemBioChem 4, 1024–1032 [DOI] [PubMed] [Google Scholar]
- 42.Yang, H., Jossinet, F., Leontis, N., Chen, L., Westbrook, J., Berman, H., and Westhof, E. (2003) Nucleic Acids Res. 31, 3450–3460 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



